glp 1 neurodegenerative disease A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular and disorders Beyond insulin: The Intriguing role

A main action is reducing the disulfide bonds in cysteine units in proteins thus reducing the protein while GSH itself is oxidized to GSSH

The Effect of Green Tea Supplementation on Obesity: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials

Stool transplants: ready for prime time

References: [1] Orrick, Herrington & Sutcliffe LLP

China 11

FIGURE 1 2 Phytochemical-based nanosystems for gene and tumor microenvironment targeting 2.1 Formulation challenges and delivery strategies While plant-derived drugs such as vincristine, paclitaxel, and docetaxel are established in oncology, they represent only a small fraction of phytochemicals with demonstrated preclinical anticancer activity that have yet to translate into routine clinical use (Figure 1) (Mazumder et al., 2022